Meanwhile, another study using breast cancer cells demonstrated TCDD-induced binding of the AhR to the COX-2 promoter, suggesting that the coordinated recruitment of the AhR, p300, and histone H4 acetylation may lead to the activation of COX-2 expression through the classical (genomic) pathway16. This evidence concerns the gene AHR and breast carcinoma.